Carolus Therapeutics, a La Jolla, CA-based biopharmaceutical company, received a $2.25m debt facility from Square 1 Bank.
The financing will support future growth.
Founded in 2008, Carolus Therapeutics develops innovative new drugs that are aimed to provide relief to patients suffering from a host of disorders triggered by acute and chronic inflammation.
The company is led by CEO Court Turner, a venture partner at Avalon Ventures, which backs Carolus.
FinSMEs
06/03/2013